Complete financial analysis of Intuitive Surgical, Inc. (ISRG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Intuitive Surgical, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Ningbo Huaxiang Electronic Co., Ltd. (002048.SZ) Income Statement Analysis – Financial Results
- Ziccum AB (publ) (ZICC.ST) Income Statement Analysis – Financial Results
- Dr. Ing. h.c. F. Porsche AG (DRPRY) Income Statement Analysis – Financial Results
- The Growth for Good Acquisition Corporation (GFGD) Income Statement Analysis – Financial Results
- Frontera Group, Inc. (FRTG) Income Statement Analysis – Financial Results
Intuitive Surgical, Inc. (ISRG)
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.12B | 6.22B | 5.71B | 4.36B | 4.48B | 3.72B | 3.13B | 2.70B | 2.38B | 2.13B | 2.27B | 2.18B | 1.76B | 1.41B | 1.05B | 874.92M | 600.83M | 372.68M | 227.34M | 138.80M | 91.68M | 72.02M | 51.67M | 26.62M | 10.19M | 0.00 |
| Cost of Revenue | 2.39B | 2.03B | 1.75B | 1.50B | 1.37B | 1.12B | 934.80M | 814.30M | 806.50M | 717.90M | 670.90M | 608.50M | 483.50M | 383.00M | 301.12M | 254.14M | 186.54M | 124.85M | 73.77M | 50.81M | 47.65M | 34.58M | 28.22M | 13.28M | 7.03M | 0.00 |
| Gross Profit | 4.73B | 4.20B | 3.96B | 2.86B | 3.11B | 2.60B | 2.19B | 1.89B | 1.58B | 1.41B | 1.59B | 1.57B | 1.27B | 1.03B | 751.05M | 620.78M | 414.29M | 247.84M | 153.57M | 87.99M | 44.03M | 37.44M | 23.46M | 13.35M | 3.16M | 0.00 |
| Gross Profit Ratio | 66.39% | 67.44% | 69.32% | 65.65% | 69.45% | 69.92% | 70.12% | 69.89% | 66.18% | 66.32% | 70.38% | 72.07% | 72.49% | 72.89% | 71.38% | 70.95% | 68.95% | 66.50% | 67.55% | 63.39% | 48.03% | 51.98% | 45.39% | 50.12% | 31.02% | 0.00% |
| Research & Development | 998.80M | 879.00M | 671.00M | 595.10M | 557.30M | 418.10M | 328.60M | 239.60M | 197.40M | 178.00M | 167.70M | 170.00M | 140.20M | 116.00M | 95.10M | 79.37M | 48.86M | 29.78M | 17.35M | 17.81M | 16.19M | 16.79M | 13.85M | 11.73M | 11.13M | 23.21M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 986.60M | 810.90M | 705.30M | 640.50M | 691.00M | 574.00M | 522.20M | 438.80M | 358.80M | 278.51M | 230.57M | 158.69M | 110.70M | 67.44M | 48.99M | 39.72M | 40.86M | 29.99M | 19.14M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.96B | 1.74B | 1.47B | 1.22B | 1.18B | 986.60M | 810.90M | 705.30M | 640.50M | 691.00M | 574.00M | 522.20M | 438.80M | 358.80M | 278.51M | 230.57M | 158.69M | 110.70M | 67.44M | 48.99M | 39.72M | 40.86M | 29.99M | 19.14M | 9.34M | 7.57M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.75M | 11.58M | 7.57M |
| Operating Expenses | 2.96B | 2.62B | 2.14B | 1.81B | 1.74B | 1.40B | 1.14B | 944.90M | 837.90M | 869.00M | 741.70M | 692.20M | 579.00M | 474.80M | 373.61M | 309.94M | 207.54M | 140.48M | 84.80M | 66.81M | 55.91M | 57.66M | 43.84M | 35.62M | 22.71M | 30.77M |
| Cost & Expenses | 5.36B | 4.65B | 3.89B | 3.31B | 3.10B | 2.52B | 2.07B | 1.76B | 1.64B | 1.59B | 741.70M | 1.30B | 1.06B | 857.80M | 674.73M | 564.08M | 394.09M | 265.33M | 158.57M | 117.62M | 103.56M | 92.24M | 72.06M | 48.90M | 29.74M | 30.77M |
| Interest Income | 192.10M | 29.70M | 69.30M | 157.20M | 116.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 29.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 421.80M | 380.40M | 317.00M | 282.50M | 199.70M | 120.10M | 95.00M | 88.90M | 89.50M | 74.40M | 67.30M | 57.80M | 46.50M | 40.40M | 34.58M | 25.08M | 13.03M | 35.27M | 6.73M | 7.11M | 10.63M | 4.55M | 4.71M | 4.75M | 2.24M | 0.00 |
| EBITDA | 2.17B | 1.58B | 1.82B | 1.05B | 1.37B | 1.32B | 1.16B | 1.05B | 740.00M | 619.20M | 919.80M | 935.90M | 741.30M | 595.60M | 377.44M | 335.92M | 219.77M | 107.36M | 75.50M | 21.18M | -1.25M | -15.67M | -15.67M | -17.53M | -17.31M | -30.77M |
| EBITDA Ratio | 30.45% | 25.35% | 31.89% | 24.09% | 30.69% | 32.21% | 33.71% | 34.95% | 31.04% | 25.56% | 37.64% | 40.30% | 39.54% | 39.29% | 35.87% | 38.39% | 36.58% | 38.27% | 33.44% | 20.21% | -1.79% | -21.70% | -30.41% | -65.42% | -169.80% | 0.00% |
| Operating Income | 1.77B | 1.21B | 1.82B | 773.60M | 1.37B | 1.20B | 1.05B | 945.20M | 740.00M | 544.80M | 852.50M | 878.10M | 694.80M | 555.20M | 377.44M | 310.84M | 206.74M | 107.36M | 68.77M | 21.18M | -11.88M | -20.22M | -20.38M | -22.28M | -19.55M | -30.77M |
| Operating Income Ratio | 24.80% | 19.47% | 31.89% | 17.75% | 30.69% | 32.21% | 33.71% | 34.95% | 31.04% | 25.56% | 37.64% | 40.30% | 39.54% | 39.29% | 35.87% | 35.53% | 34.41% | 28.81% | 30.25% | 15.26% | -12.96% | -28.07% | -39.45% | -83.67% | -191.81% | 0.00% |
| Total Other Income/Expenses | 192.10M | 29.70M | 69.30M | 157.20M | 127.70M | 80.10M | 41.90M | 35.60M | 18.50M | 4.20M | 18.40M | 15.80M | 14.90M | 17.10M | 18.67M | 24.37M | 30.49M | 12.78M | 5.04M | 3.02M | 2.26M | 1.80M | 42.00K | -108.00K | 0.00 | 0.00 |
| Income Before Tax | 1.96B | 1.61B | 1.89B | 1.21B | 1.50B | 1.28B | 1.10B | 980.80M | 758.50M | 549.00M | 870.90M | 893.90M | 709.70M | 572.30M | 396.11M | 335.20M | 237.23M | 120.14M | 73.81M | 24.20M | -9.62M | -18.42M | -20.34M | -22.39M | 0.00 | 0.00 |
| Income Before Tax Ratio | 27.50% | 25.82% | 33.10% | 27.69% | 33.54% | 34.36% | 35.04% | 36.27% | 31.81% | 25.75% | 38.45% | 41.03% | 40.39% | 40.50% | 37.65% | 38.31% | 39.48% | 32.24% | 32.47% | 17.44% | -10.50% | -25.58% | -39.36% | -84.08% | 0.00% | 0.00% |
| Income Tax Expense | 141.60M | 262.40M | 162.20M | 140.20M | 120.40M | 154.50M | 436.50M | 244.90M | 169.70M | 130.20M | 199.90M | 237.30M | 214.60M | 190.50M | 163.51M | 130.89M | 92.70M | 48.09M | -20.33M | 726.00K | -2.26M | -1.80M | -3.68M | -3.75M | -1.13M | 29.44M |
| Net Income | 1.80B | 1.32B | 1.70B | 1.06B | 1.38B | 1.13B | 660.00M | 735.90M | 588.80M | 418.80M | 671.00M | 656.60M | 495.10M | 381.80M | 232.61M | 204.32M | 144.54M | 72.04M | 94.13M | 23.48M | -9.62M | -18.42M | -16.70M | -18.52M | -18.42M | -29.44M |
| Net Income Ratio | 25.24% | 21.25% | 29.85% | 24.33% | 30.80% | 30.29% | 21.09% | 27.21% | 24.69% | 19.65% | 29.62% | 30.14% | 28.17% | 27.02% | 22.11% | 23.35% | 24.06% | 19.33% | 41.41% | 16.91% | -10.50% | -25.58% | -32.32% | -69.57% | -180.68% | 0.00% |
| EPS | 5.12 | 3.72 | 4.79 | 3.02 | 3.98 | 3.31 | 1.97 | 2.13 | 1.76 | 1.26 | 1.86 | 1.83 | 1.40 | 1.08 | 0.67 | 0.58 | 0.42 | 0.22 | 0.30 | 0.08 | -0.05 | -0.11 | -0.10 | -0.17 | -0.85 | -1.81 |
| EPS Diluted | 5.03 | 3.65 | 4.66 | 2.94 | 3.85 | 3.16 | 1.89 | 2.08 | 1.73 | 1.23 | 1.86 | 1.78 | 1.37 | 1.05 | 0.66 | 0.57 | 0.41 | 0.21 | 0.28 | 0.07 | -0.05 | -0.11 | -0.10 | -0.17 | -0.85 | -1.81 |
| Weighted Avg Shares Out | 351.20M | 355.70M | 356.10M | 351.00M | 346.20M | 341.10M | 335.10M | 344.70M | 333.90M | 332.10M | 360.97M | 358.20M | 352.80M | 352.80M | 344.68M | 349.89M | 340.48M | 330.63M | 315.63M | 303.24M | 212.63M | 164.06M | 161.17M | 107.08M | 21.77M | 16.29M |
| Weighted Avg Shares Out (Dil) | 357.40M | 362.00M | 365.80M | 360.90M | 358.50M | 356.40M | 348.90M | 353.70M | 341.10M | 339.30M | 360.97M | 369.90M | 361.80M | 362.70M | 352.85M | 359.49M | 351.19M | 342.84M | 337.39M | 314.78M | 212.63M | 164.06M | 161.17M | 107.08M | 21.77M | 16.29M |
Intuitive Surgical Offers Low Risk, High Return Despite Valuation Concerns
Intuitive Surgical remains a leader in robotic surgery despite intensifying competition from Medtronic and Johnson & Johnson. The company's da Vinci procedures grew 17% year-over-year, driving growth in system sales and recurring revenue. Intuitive Surgical reported strong Q2 2024 earnings,...
Bull Market Buys: 2 Nasdaq Stocks to Own for the Long Run
Consumer spending habits have shifted, but essentials like healthcare and key staples remain resilient categories. Intuitive Surgical benefits from market leadership in its niche, a wide moat, and a clever business model.
Intuitive Surgical Has Stellar Performance, but Is Priced to Perfection
Robotic surgical systems provider Intuitive Surgical Inc. (ISRG, Financial) has been one of the hottest stocks over the past year, consistently notching higher highs and many from the Wall Street punditry expecting more upside ahead. Moreover, recent quarterly updates show...
Here's Why Intuitive Surgical, Inc. (ISRG) Gained But Lagged the Market Today
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $490.01, denoting a +1.64% change from the preceding trading day.
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do...
Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $483.32, signifying a -1.64% move from its prior day's close.
ISRG Stock Rallies 14% in 3 Months: Is It Still Worth Buying?
Intuitive Surgical is making strides in the robotic-assisted surgery market with its existing and new launches. However, macro challenges are likely to continue to hurt its performance.
Rate Cuts or Not, These 3 Stocks Are Poised to Outperform
Investors are on edge as the Federal Reserve prepares to make its next interest rate decision. While some scramble for cover, seasoned investors seek opportunities in companies poised to weather the storm and thrive, regardless of the Fed's move.
Zacks Industry Outlook Intuitive Surgical, Masimo and Veracyte
Chicago, IL – September 16, 2024 – Today, Zacks Equity Research discusses Intuitive Surgical ISRG, Masimo Corp. MASI and Veracyte, Inc. VCYT.
3 Medical Instruments Industry Stocks to Buy on genAI and M&A Boost
ISRG, MASI and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and supply issues mar the prospects.
Source: https://incomestatements.info
Category: Stock Reports